NasdaqCM - Nasdaq Real Time Price USD

Bon Natural Life Limited (BON)

Compare
1.4110 -0.0090 (-0.63%)
As of 9:39 AM EST. Market Open.
Loading Chart for BON
DELL
  • Previous Close 1.4200
  • Open 1.4100
  • Bid --
  • Ask --
  • Day's Range 1.4100 - 1.4110
  • 52 Week Range 1.2300 - 6.9900
  • Volume 500
  • Avg. Volume 42,495
  • Market Cap (intraday) 5.602M
  • Beta (5Y Monthly) -1.18
  • PE Ratio (TTM) 0.30
  • EPS (TTM) 4.7500
  • Earnings Date Nov 21, 2024 - Dec 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

www.bnlus.com

96

Full Time Employees

September 30

Fiscal Year Ends

Recent News: BON

View More

Performance Overview: BON

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BON
73.87%
S&P 500
24.01%

1-Year Return

BON
67.93%
S&P 500
30.07%

3-Year Return

BON
97.55%
S&P 500
25.90%

5-Year Return

BON
97.76%
S&P 500
38.64%

Compare To: BON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BON

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    5.84M

  • Enterprise Value

    11.59M

  • Trailing P/E

    0.31

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.08

  • Price/Book (mrq)

    0.16

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    2.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.65%

  • Return on Assets (ttm)

    3.88%

  • Return on Equity (ttm)

    6.61%

  • Revenue (ttm)

    25.56M

  • Net Income Avi to Common (ttm)

    2.47M

  • Diluted EPS (ttm)

    4.7500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    717.88k

  • Total Debt/Equity (mrq)

    17.84%

  • Levered Free Cash Flow (ttm)

    -978.17k

Research Analysis: BON

View More

Company Insights: BON

Research Reports: BON

View More

People Also Watch